Clinical Trials Browser

Unknown × Breast Neoplasms × Erlotinib Hydrochloride × Clear all

NCT04591431 2023-10-03

ROME

Phase 2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

NCT00491816 2017-01-19

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Neoplasms